Lido Advisors’s scPharmaceuticals SCPH Stock Holding History

Lido Advisors’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-27,470	Closed	-$156K	–	1941
2025 Q3	$156K	Sell	27,470 -30	-0.1%	-$154	﹤0.01%	1718
2025 Q2	$105K	Buy	27,500 +3,500	+15%	+$10.9K	﹤0.01%	1587
2025 Q1	$63.1K	Buy	+24,000	New	+$78.2K	﹤0.01%	1467

Lido Advisors's SCPH Position: Q4 2025 in Review

Lido Advisors sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 27,470 shares — an estimated $156K sold.

Lido Advisors first reported a position in SCPH in Q1 2025 and held it in 3 quarters. The position peaked at $156K in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Lido Advisors reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Lido Advisors sold 27,470 scPharmaceuticals shares in Q4 2025, an estimated $156K.
Lido Advisors first reported a position in scPharmaceuticals in Q1 2025 and held it in 3 quarters.
Lido Advisors's scPharmaceuticals position peaked at $156K in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Lido Advisors's 13F filing for Q4 2025, filed 10 Feb 2026.